Buscar en
Gastroenterología y Hepatología (English Edition)
Toda la web
Inicio Gastroenterología y Hepatología (English Edition) Skin injuries associated with biological therapy in inflammatory bowel disease: ...
Journal Information
Vol. 45. Issue 1.
Pages 62-63 (January 2022)
Vol. 45. Issue 1.
Pages 62-63 (January 2022)
Image of the month
Full text access
Skin injuries associated with biological therapy in inflammatory bowel disease: Beyond psoriasis
Lesiones cutáneas con fármacos biológicos en la enfermedad inflamatoria intestinal: más allá de la psoriasis
Visits
72
Alejandro Mínguez Sabater
Corresponding author
alejandromsab11@gmail.com

Corresponding author.
, Sara Martínez Delgado, Pablo Ladrón Abia, Guillermo Bastida
Sección de Gastroenterología, Departamento de Medicina Digestiva, Hospital Universitario y Politécnico La Fe, Valencia, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

We report the case of a 43-year-old man with Crohn’s disease of the ileum and colon. He was treated initially with steroids and azathioprine and then with adalimumab (ADA). He remained stable until four years ago, when he developed complex perianal disease (PAD). As ADA failed to manage his PAD, he was started on vedolizumab (VDZ) (Fig. 1).

Figure 1.

Palmar–plantar involvement in the form of erythematous papules with a hyperkeratotic scaly collarette that may take on a psoriasiform appearance. Larger lesion in the form of localised hyperkeratosis (black arrow).

(0.08MB).

The treatment with VDZ brought both his bowel signs and symptoms and his PAD under control. After three years of this treatment, the patient developed a pruriginous palmar–plantar hyperkeratotic maculopapular rash. In his family history, he had a brother with psoriasis. Dermatology diagnosed him by serology with secondary syphilis; he responded well to antibiotic treatment.

Biological drugs are a commonly used treatment tool in inflammatory bowel disease. Their adverse effects include the development of psoriasiform lesions, classically reported with TNF inhibitors, though also with other drugs such as VDZ.1,2 In many cases, the drug has to be discontinued; therefore, a good differential diagnosis of these lesions with infectious diseases such as syphilis is essential.3,4 The characteristic sign of secondary syphilis is palmar–plantar involvement manifesting as erythematous papules with a scaly collarette that may take on a psoriasiform appearance. Nail involvement is rare. Treatment does not require discontinuation of the biological drug, but rather antibiotic therapy with penicillin.4,5

Funding

The authors declare that they received no funding to conduct this study.

References
[1]
E. Fréling, C. Baumann, J.F. Cuny, M.A. Bigard, J.L. Schmutz, A. Barbaud, et al.
Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
Am J Gastroenterol, 110 (2015), pp. 1186-1196
[2]
E. Sody, A. Körber.
Psoriasis induced by vedolizumab.
Inflamm Bowel Dis, 23 (2017), pp. 9-11
[3]
M.J. Bittencourt, A.C. Brito, B.A. Nascimento, A.H. Carvalho, M.D. Nascimento.
A case of secondary syphilis mimicking palmoplantar psoriasis in HIV infected patient.
An Bras Dermatol, 90 (2015), pp. 216-219
[4]
S. Gianfaldoni, G. Tchernev, U. Wollina, R. Gianfaldoni, T. Lotti.
Secondary syphilis presenting as palmoplantar psoriasis.
Open Access Maced J Med Sci, 5 (2017), pp. 445-447
[5]
S. Lopes, M. Costa-Silva, S. Magina, M. Silva, F. Margo.
Concurrent lip chancre and maculopapular syphilides in a patient under anti-TNFα therapy.
Skinmed, 17 (2019), pp. 343-345

Please cite this article as: Mínguez Sabater A, Martínez Delgado S, Ladrón Abia P, Bastida G. Lesiones cutáneas con fármacos biológicos en la enfermedad inflamatoria intestinal: más allá de la psoriasis. Gastroenterol Hepatol. 2022;45:62–63.

Copyright © 2020. Elsevier España, S.L.U.. All rights reserved
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos